アブストラクト
Title | 慢性膵炎に対する薬物治療 |
---|---|
Subtitle | 特集 慢性膵炎診療の最前線 |
Authors | 藤森尚1), 原真児登1), 梯祥太郎1), 安森翔1), 村上正俊1), 松本一秀1), 寺松克人1), 高松悠1), 竹野歩1), 大野隆真1), 伊藤鉄英2,3), 小川佳宏1) |
Authors (kana) | |
Organization | 1)九州大学大学院医学研究院病態制御内科学, 2)福岡山王病院膵臓内科・神経内分泌腫瘍センター, 3)国際福祉医療大学大学院医学研究科消化器内科 |
Journal | 胆と膵 |
Volume | 42 |
Number | 2 |
Page | 113-116 |
Year/Month | 2021 / 2 |
Article | 報告 |
Publisher | 医学図書出版 |
Abstract | 「要約」 : 慢性膵炎診療においては, 慢性膵炎の成因・症状の有無・膵内外分泌機能・画像所見・病期などを総合的に評価することが重要である. 治療に関しては, 断酒・禁煙などの生活指導および栄養指導を適切に行ったうえで, 薬物療法を検討する. 鎮痛剤や蛋白分解酵素阻害剤による疼痛対策, 膵外分泌機能低下に対する膵消化酵素薬や胃酸分泌抑制薬, 膵内分泌機能低下に対する糖尿病治療, が薬物治療の主体となる. 症状の有無や病期, さらに膵内外分泌機能を適切に評価したうえで, これらの薬物治療を組み合わせるとともに, 慢性膵炎の長期経過を視野に入れた診療が望まれる. |
Practice | 臨床医学:内科系 |
Keywords | 慢性膵炎, 薬物療法, 膵内外分泌機能 |
- 全文ダウンロード: 従量制、基本料金制の方共に1,023円(税込) です。
参考文献
- 1) 日本膵臓学会膵炎調査研究委員会慢性膵炎分科会:慢性膵炎臨床診断基準 2019. 膵臓 34:279-281,2019.
- 2) 藤森 尚, 末廣侑大, 村上正俊, ほか:喫煙と慢性膵炎の関係-基礎研究と疫学調査のデータから-. 肝・胆・膵 80:259-263,2020.
- 3) Singh VK, Yadav D. Garg PK:Diagnosis and man-agement of chronic pancreatitis: a review. JAMA 322:2422-2434,2019.
- 4) 阪上順一, 香川惠造, 保田宏明, ほか:慢性膵炎の治療(1)治療の基本方針. 臨消内科 35:1353-1363,2020.
- 5) Arvanitakis M, Ockenga J, Bezmarevic M, et al.:ESPEN guideline on clinical nutrition in acute and chronic pancreatitis. Clin Nutr 39:612-631,2020.
残りの20件を表示する
- 6) Kataoka K, Sakagami J, Hirota M, et al.:Effects of oral ingestion of the elemental diet in patients with painful chronic pancreatitis in the real-life setting in Japan. Pancreas 43:451-457,2014.
- 7) 日本消化器病学会:慢性膵炎診療ガイドライン 2015改訂第2版. 南江堂, 2015.
- 8) Wilder-Smith CH, Hill L, Osler W, et al.:Effect of tramadol and morphine on pain and gastrointestinal motor function in patients with chronic pancreatitis. Dig Dis Sci 44:1107-1116,1999.
- 9) 伊藤鉄英, 宜保淳也, 藤山 隆, ほか:慢性膵炎非代償期に蛋白分解酵素阻害薬は不要か. 肝・胆・膵 80:323-328,2020.
- 10) Gibo J, Ito T, Kawabe K, et al.:Camostat mesilate attenuates pancreatic fibrosis via inhibition of mono-cytes and pancreatic stellate cells activity. Lab Invest 85:75-89,2005.
- 11) Yamawaki H, Futagami S, Kaneko K, et al.:Camostat mesilate, pancrelipase, and rabeprazole combination therapy improves epigastric pain in early chronic pancreatitis and functional dyspepsia with pancreatic enzyme abnormalities. Digestion 99:283-292,2019.
- 12) 洪 繁:我が国で処方可能な各種消化酵素製剤の特長とそれに応じた製剤の使い分け. 膵臓 32:125-139,2017.
- 13) Whitcomb DC, Lehman GA, Vasileva G, et al.:Pan-crelipase delayed-release capsules(CREON)for exocrine pancreatic insufficiency due to chronic pan-creatitis or pancreatic surgery: a double-blind ran-domized trial. Am J Gastroenterol 105:2276-2286,2010.
- 14) Gubergrits N, Malecka-Panas E, Lehman GA, et al.: A 6-month, open-label clinical trial of pancrelipase delayed-release capsules(Creon)in patients with exocrine pancreatic insufficiency due to chronic pan-creatitis or pancreatic surgery. Aliment Pharmacol Ther 33:1152-1161,2011.
- 15) Thorat V, Reddy N, Bhatia S, et al.:Randomised clinical trial:the efficacy and safety of pancreatin enteric-coated minimicrospheres(Creon 40000 MMS)in patients with pancreatic exocrine insuffi-ciency due to chronic pancreatitis-a double-blind, placebo-controlled study. Aliment Pharmacol Ther 36:426-436,2012.
- 16) De La Iglesia-Garcia D, Huang W, Szatmary P, et al.:Efficacy of pancreatic enzyme replacement ther-apy in chronic pancreatitis:systematic review and meta-analysis. Gut 66:1354-1355,2017.
- 17) Yaghoobi M, McNabb-Baltar J, Bijarchi R, et al.:Pancreatic enzyme supplements are not effective for relieving abdominal pain in patients with chronic pancreatitis:meta-analysis and systematic review of randomized controlled trials. Can J Gastroenterol Hepatol 2016:8541839,2016.
- 18) Marotta F, O'keefe SJ, Marks IN, et al.:Pancreatic enzyme replacement therapy. Importance of gastric acid secretion, H2-antagonists, and enteric coating. Dig Dis Sci 34:456-461,1989.
- 19) Dominguez-Muioz JE, Iglesias-Garcia J, Iglesias-Rey M, et al.:Optimising the therapy of exocrine pancre-atic insufficiency by the association of a proton pump inhibitor to enteric coated pancreatic extracts. Gut 55:1056-1057,2006.
- 20) Jalal M, Campbell JA, Hopper AD:Practical guide to the management of chronic pancreatitis. Frontline Gastroenterol 10:253-260,2019.
- 21) Dominguez-Munoz JE:Pancreatic enzyme replace-ment therapy for pancreatic exocrine insufficiency:when is it indicated, what is the goal and how to do it? Adv Med Sci 56:1-5.2011.
- 22) Nakamura T, Arai Y, Tando Y, et al.:Effect of omeprazole on changes in gastric and upper small intestine pH levels in patients with chronic pancre-atitis. Clin Ther 17:448-459,1995.
- 23) Ito T, Otsuki M, Igarashi H, et al.:Epidemiological study of pancreatic diabetes in Japan in 2005: a nationwide study. Pancreas 39:829-835,2010.
- 24) Ewald N, Hardt PD:Diagnosis and treatment of dia-betes mellitus in chronic pancreatitis. World J Gas-troenterol 19:7276-7281,2013.
- 25) 藤森 尚, 末廣侑大, 村上正俊, ほか:膵性糖尿病の診断と治療. 胆と膵 40:1179-1183,2019.